CoChat

Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids

Open access
Rossmeisl, Martin, Macek Jilkova, Zuzana, Kuda, Ondrej, Jelenik, Tomas, Medrikova, Dasa, Stankova, Barbora, Kristinsson, Björn, Haraldsson, Gudmundur G., Svensen, Harald, Stoknes, Iren, Sjövall, Peter, Magnusson, Ylva, Balvers, Michiel G. J., Verhoeckx, Kitty C. M., Tvrzicka, Eva, Bryhn, Morten, Kopecky, Jan · 2012 · PLoS ONE

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

BACKGROUND: n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity-associated disorders. We hypothesised that the latter effect will be more pronounced when DHA/EPA is supplemented as phospholipids rather than as triglycerides. METHODOLOGY/PRINCIPAL FINDINGS: In a 'prevention study', C57BL/6J mice were fed for 9 weeks on either a corn oil-based high-fat obesogenic diet (cHF; lipids ∼35% wt/wt), or cHF-based diets in which corn oil was partially replaced by DHA/EPA, admixed either as phospholipids or triglycerides from marine fish. The reversal of obesity was studied in mice subjected to the preceding cHF-feeding for 4 months. DHA/EPA administered as phospholipids prevented glucose intolerance and tended to reduce obesity better than triglycerides. Lipemia and hepatosteatosis were suppressed more in response to dietary phospholipids, in correlation with better bioavailability of DHA and EPA, and a higher DHA accumulation in the liver, white adipose tissue (WAT), and muscle phospholipids. In dietary obese mice, both DHA/EPA concentrates prevented a further weight gain, reduced plasma lipid levels to a similar extent, and tended to improve glucose tolerance. Importantly, only the phospholipid form reduced plasma insulin and adipocyte hypertrophy, while being more effective in reducing hepatic steatosis and low-grade inflammation of WAT. These beneficial effects were correlated with changes of endocannabinoid metabolome in WAT, where phospholipids reduced 2-arachidonoylglycerol, and were more effective in increasing anti-inflammatory lipids such as N-docosahexaenoylethanolamine. CONCLUSIONS/SIGNIFICANCE: Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0038834

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Timeline of dietary studies. All mice were weaned on Chow diet at 4 weeks of age. In the ‘prevention’ and ‘bioavailability’ studies, 3-month-old mice were switched from Chow to cHF, cHF+ω3TG and cHF+ω3PL diets for a period of 2 or 9 weeks, respectively, as indicated. In the ‘reversal study’, mice were fed cHF diet for a period of 4 month, followed by 9-week-feeding using cHF, cHF+ω3TG and cHF+ω3PL diets. In the ‘bioavailability’ study, cHF+ω3TG and cHF+ω3PL diets with several different concentrations of DHA and EPA were used (see Methods and Figure 2A,B), while in the ‘prevention’ and ‘reversal’ studies these diets were matched for their DHA/EPA content (i.e. 30 g DHA/EPA per kg diet), except for the ‘prevention’ study, in which a subgroup of mice was also treated using cHF+ω3PL diet containing 10 g DHA/EPA per kg diet. See Methods for further details. IPGTT, intraperitoneal (i.p.) glucose tolerance tests.
Figure 1 Timeline of dietary studies. All mice were weaned on Chow diet at 4 weeks of age. In the ‘prevention’ and ‘bioavailability’ studies, 3-month-old mice were switched from Chow to cHF, cHF+ω3TG and cHF+ω3PL diets for a period of 2 or 9 weeks, respectively, as indicated. In the ‘reversal study’, mice were fed cHF diet for a period of 4 month, followed by 9-week-feeding using cHF, cHF+ω3TG and cHF+ω3PL diets. In the ‘bioavailability’ study, cHF+ω3TG and cHF+ω3PL diets with several different concentrations of DHA and EPA were used (see Methods and Figure 2A,B), while in the ‘prevention’ and ‘reversal’ studies these diets were matched for their DHA/EPA content (i.e. 30 g DHA/EPA per kg diet), except for the ‘prevention’ study, in which a subgroup of mice was also treated using cHF+ω3PL diet containing 10 g DHA/EPA per kg diet. See Methods for further details. IPGTT, intraperitoneal (i.p.) glucose tolerance tests.CC BY · PubMed Central
Figure 2 Bioavailability of DHA and EPA and their accumulation in the liver and WAT in the ‘prevention study’. A,B Fatty acid (FA) composition of total lipids in plasma was analyzed in mice fed for 2 weeks with the cHF+ω3TG (red circles) or cHF+ω3PL (blue circles) diet with various concentrations of DHA/EPA. The correlation plots between dietary content and the corresponding increments in plasma concentrations of DHA (A) and EPA (B) corrected for the values in the cHF-fed mice (DHA, 2.49–2.84 mol %; EPA, 0.05–0.16 mol %; see also Fig. 2C,D). The coefficient of determination (R2), describing the proportion of the dependent variable that is explained by the independent variable, is also shown. The concentration of DHA (C) and EPA (D) in total plasma lipids, liver triglycerides (TG) and phospholipid (PL) fraction, and in total lipids from epididymal white adipose tissue (WAT) was assessed in mice from the ‘prevention study’ following 9 weeks of feeding cHF+ω3TG (red bars) and cHF+ω3PL (blue bars) diets supplemented with 30 g DHA/EPA per kg, or the control cHF diet (black bars). For the detailed data on fatty acid composition, see Tables S4, S5, S6, S7). Data are means±SEM (n = 4−7); if SEM is not shown, it is smaller than the symbol size (A,B). *Significantly different from cHF+ω3TG (ANOVA).
Figure 2 Bioavailability of DHA and EPA and their accumulation in the liver and WAT in the ‘prevention study’. A,B Fatty acid (FA) composition of total lipids in plasma was analyzed in mice fed for 2 weeks with the cHF+ω3TG (red circles) or cHF+ω3PL (blue circles) diet with various concentrations of DHA/EPA. The correlation plots between dietary content and the corresponding increments in plasma concentrations of DHA (A) and EPA (B) corrected for the values in the cHF-fed mice (DHA, 2.49–2.84 mol %; EPA, 0.05–0.16 mol %; see also Fig. 2C,D). The coefficient of determination (R2), describing the proportion of the dependent variable that is explained by the independent variable, is also shown. The concentration of DHA (C) and EPA (D) in total plasma lipids, liver triglycerides (TG) and phospholipid (PL) fraction, and in total lipids from epididymal white adipose tissue (WAT) was assessed in mice from the ‘prevention study’ following 9 weeks of feeding cHF+ω3TG (red bars) and cHF+ω3PL (blue bars) diets supplemented with 30 g DHA/EPA per kg, or the control cHF diet (black bars). For the detailed data on fatty acid composition, see Tables S4, S5, S6, S7). Data are means±SEM (n = 4−7); if SEM is not shown, it is smaller than the symbol size (A,B). *Significantly different from cHF+ω3TG (ANOVA).CC BY · PubMed Central
Figure 3 Changes in the lipid spectra in response to dietary LC n-3 PUFA in selected tissues of mice in the ‘prevention study’. Mice were fed for 9 weeks the cHF (black triangles), cHF+ω3TG (red circles), or cHF+ω3PL (blue circles) diet, while the last two diets were supplemented with 30 g DHA/EPA per kg. In total, 59, 71 and 61 lipid species were quantified in the liver, epididymal WAT and skeletal muscle, respectively, using time-of-flight secondary ion mass spectrometry (TOF-SIMS) analysis (see also Table S8, S9, S10). Means±SEM of 3–6 TOF-SIMS spectra from 3 animals per each group were used for orthogonal partial least squares-discriminant analysis (oPLS-DA). Score plots of the liver (A), WAT (B) and skeletal muscle (C) and corresponding variable important to projection (VIP) plots for the first latent variable (D, E, F), respectively. Only variables with VIP scores greater than 1 (denoted by a dashed horizontal line; D-F) and narrow confidence intervals were used for further evaluations, and only those discriminating between cHF+ω3TG and cHF+ω3PL diets (gray bars, D-F) were plotted (G; cHF diet, black bars; cHF+ω3TG diet, red bars; cHF+ω3PL diet; blue bars). See also Fig. S3 for additional lipid species identified. DAG, diacylglycerol. *Significantly different from cHF (all analyses by ANOVA).
Figure 3 Changes in the lipid spectra in response to dietary LC n-3 PUFA in selected tissues of mice in the ‘prevention study’. Mice were fed for 9 weeks the cHF (black triangles), cHF+ω3TG (red circles), or cHF+ω3PL (blue circles) diet, while the last two diets were supplemented with 30 g DHA/EPA per kg. In total, 59, 71 and 61 lipid species were quantified in the liver, epididymal WAT and skeletal muscle, respectively, using time-of-flight secondary ion mass spectrometry (TOF-SIMS) analysis (see also Table S8, S9, S10). Means±SEM of 3–6 TOF-SIMS spectra from 3 animals per each group were used for orthogonal partial least squares-discriminant analysis (oPLS-DA). Score plots of the liver (A), WAT (B) and skeletal muscle (C) and corresponding variable important to projection (VIP) plots for the first latent variable (D, E, F), respectively. Only variables with VIP scores greater than 1 (denoted by a dashed horizontal line; D-F) and narrow confidence intervals were used for further evaluations, and only those discriminating between cHF+ω3TG and cHF+ω3PL diets (gray bars, D-F) were plotted (G; cHF diet, black bars; cHF+ω3TG diet, red bars; cHF+ω3PL diet; blue bars). See also Fig. S3 for additional lipid species identified. DAG, diacylglycerol. *Significantly different from cHF (all analyses by ANOVA).CC BY · PubMed Central
Figure 4 Reversal of hepatic lipid accumulation by dietary LC n-3 PUFA. Following a 4-month period of cHF-feeding, mice were fed for additional 9 weeks with cHF diet or treated using either cHF+ω3TG or cHF+ω3PL diet supplemented with 30 g DHA/EPA per kg; all diets also contained 2 g metformin per kg. Hematoxyline-eosin staining of liver sections from mice fed cHF (A), cHF+ω3TG (B), or cHF+ω3PL (C) diet. Hepatic lipid content (D). Quantification of mRNA levels of fatty acid oxidation (E) and lipogenic (F) genes in mice fed cHF (black bars), cHF+ω3TG (red bars), or cHF+ω3PL (blue bars) diets. A-C, Scale bars = 200 µm. AOX, acyl-CoA oxidase; ACOT2, acyl-CoA thioesterase 2; FAS; fatty acid synthase; SCD-1, stearoyl-CoA desaturase 1. Data are means±SEM (n = 7). *Significantly different from cHF (t-test or ANOVA); †significantly different from cHF+ω3TG (ANOVA).
Figure 4 Reversal of hepatic lipid accumulation by dietary LC n-3 PUFA. Following a 4-month period of cHF-feeding, mice were fed for additional 9 weeks with cHF diet or treated using either cHF+ω3TG or cHF+ω3PL diet supplemented with 30 g DHA/EPA per kg; all diets also contained 2 g metformin per kg. Hematoxyline-eosin staining of liver sections from mice fed cHF (A), cHF+ω3TG (B), or cHF+ω3PL (C) diet. Hepatic lipid content (D). Quantification of mRNA levels of fatty acid oxidation (E) and lipogenic (F) genes in mice fed cHF (black bars), cHF+ω3TG (red bars), or cHF+ω3PL (blue bars) diets. A-C, Scale bars = 200 µm. AOX, acyl-CoA oxidase; ACOT2, acyl-CoA thioesterase 2; FAS; fatty acid synthase; SCD-1, stearoyl-CoA desaturase 1. Data are means±SEM (n = 7). *Significantly different from cHF (t-test or ANOVA); †significantly different from cHF+ω3TG (ANOVA).CC BY · PubMed Central
Figure 5 Reversal of adipose tissue hypertrophy and low-grade inflammation by dietary LC n-3 PUFA. Following a 4-month period of cHF-feeding, mice were fed for additional 9 weeks with cHF diet or treated using either cHF+ω3TG or cHF+ω3PL diet supplemented with 30 g DHA/EPA per kg; all diets also contained 2 g metformin per kg. Hematoxyline-eosin staining of epididymal fat sections from mice fed cHF (A), cHF+ω3TG (B), or cHF+ω3PL (C) diet. D Adipocyte size; morphometric analysis was based on more than 1,000 cells taken randomly from 5 different areas per animal (n = 3). E Amount of MAC-2 immunoreactive macrophages in the above tissue sections, expressed as the number of crown-like structures (CLS; indicated by white arrows in A–C). F Adipose tissue gene expression of monocyte chemoattractant protein-1 (MCP-1), a chemokine which is involved in the recruitment of monocytes to sites of injury and infection. cHF diet, black bars; cHF+ω3TG diet, red bars; cHF+ω3PL diet; blue bars. A-C, Scale bars = 200 µm. Data are means±SEM (n = 7−8; D–F). *Significantly different from cHF; †significantly different from cHF+ω3TG (all analyses by ANOVA).
Figure 5 Reversal of adipose tissue hypertrophy and low-grade inflammation by dietary LC n-3 PUFA. Following a 4-month period of cHF-feeding, mice were fed for additional 9 weeks with cHF diet or treated using either cHF+ω3TG or cHF+ω3PL diet supplemented with 30 g DHA/EPA per kg; all diets also contained 2 g metformin per kg. Hematoxyline-eosin staining of epididymal fat sections from mice fed cHF (A), cHF+ω3TG (B), or cHF+ω3PL (C) diet. D Adipocyte size; morphometric analysis was based on more than 1,000 cells taken randomly from 5 different areas per animal (n = 3). E Amount of MAC-2 immunoreactive macrophages in the above tissue sections, expressed as the number of crown-like structures (CLS; indicated by white arrows in A–C). F Adipose tissue gene expression of monocyte chemoattractant protein-1 (MCP-1), a chemokine which is involved in the recruitment of monocytes to sites of injury and infection. cHF diet, black bars; cHF+ω3TG diet, red bars; cHF+ω3PL diet; blue bars. A-C, Scale bars = 200 µm. Data are means±SEM (n = 7−8; D–F). *Significantly different from cHF; †significantly different from cHF+ω3TG (all analyses by ANOVA).CC BY · PubMed Central
Figure 6 Modulation of adipose tissue levels of endocannabinoids and endocannabinoid-like molecules by dietary LC n-3 PUFA in the ‘reversal study’. Following a 4-month-period of cHF-feeding, mice were fed for additional 9 weeks cHF diet, or treated using either cHF+ω3TG or cHF+ω3PL diet supplemented with 30 g DHA/EPA per kg; all diets also contained 2 g metformin per kg. The effects of LC n-3 PUFA supplementation on adipose tissue levels of 2-arachidonoylglycerol (2-AG) and anandamide (AEA; A), as well as on the levels of N-eicosapentaenoylethanolamine (EPEA) and N-docosahexaenoylethanolamine (DHEA; B); cHF, black bars; cHF+ω3TG, red bars; cHF+ω3PL, blue bars. The relationship between adipocyte size and adipose tissue levels of either 2-AG (C) or DHEA (D) in mice fed cHF (black triangles), cHF+ω3TG (red circles), or cHF+ω3PL (blue circles) diet. Data are means±SEM (n = 8–9). *Significantly different from cHF (t-test or ANOVA); †significantly different from cHF+ω3TG (ANOVA).
Figure 6 Modulation of adipose tissue levels of endocannabinoids and endocannabinoid-like molecules by dietary LC n-3 PUFA in the ‘reversal study’. Following a 4-month-period of cHF-feeding, mice were fed for additional 9 weeks cHF diet, or treated using either cHF+ω3TG or cHF+ω3PL diet supplemented with 30 g DHA/EPA per kg; all diets also contained 2 g metformin per kg. The effects of LC n-3 PUFA supplementation on adipose tissue levels of 2-arachidonoylglycerol (2-AG) and anandamide (AEA; A), as well as on the levels of N-eicosapentaenoylethanolamine (EPEA) and N-docosahexaenoylethanolamine (DHEA; B); cHF, black bars; cHF+ω3TG, red bars; cHF+ω3PL, blue bars. The relationship between adipocyte size and adipose tissue levels of either 2-AG (C) or DHEA (D) in mice fed cHF (black triangles), cHF+ω3TG (red circles), or cHF+ω3PL (blue circles) diet. Data are means±SEM (n = 8–9). *Significantly different from cHF (t-test or ANOVA); †significantly different from cHF+ω3TG (ANOVA).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 243

Metadata

Authors
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., Sjövall, P., Magnusson, Y., Balvers, M. G. J., Verhoeckx, K. C. M., Tvrzicka, E., Bryhn, M., & Kopecky, J.
Affiliations
  • Czech Academy of Sciences (CZ)
  • University of Iceland (IS)
  • RISE Research Institutes of Sweden (SE)
  • Sahlgrenska University Hospital (SE)
  • Netherlands Organisation for Applied Scientific Research (NL)
Venue
PLoS ONE
Published
2012-06-11
Volume
7
Issue
6
Pages
e38834
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2038831823
Cited by
230
References
62
Citations by year
2026: 4 · 2025: 7 · 2024: 6 · 2023: 15 · 2022: 7 · 2021: 21 · 2020: 23 · 2019: 24 · 2018: 20 · 2017: 24 · 2016: 22 · 2015: 19 · 2014: 17 · 2013: 19 · 2012: 2
FWCI
17.03
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TNO Repository (submittedVersion)
  • ASEP (submittedVersion, public-domain)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Socio-Environmental Systems Modeling (submittedVersion)
  • Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Grantová Agentura České Republiky (GAP301/10/1420)
  • VINNOVA
  • Ministerstvo Zdravotnictví Ceské Republiky
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
omega-3 fatty acids, docosahexaenoic acid, eicosapentaenoic acid, phospholipids, triglycerides, high-fat diet, obesity, endocannabinoids, 2-arachidonoylglycerol, hepatic steatosis, adipose tissue inflammation, adipocyte hypertrophy, insulin, impaired glucose tolerance, fatty acid bioavailability, marine fish oil
MeSH terms
Analysis of Variance, Animals, Biological Availability, Body Weight, Docosahexaenoic Acids, Immunohistochemistry, Liver, Male, Mice, Inbred C57BL, Microscopy, Obesity, Phospholipids, Triglycerides, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Muscle, Skeletal, Mice, Adipose Tissue, White, Metabolomics, Diet, High-Fat, Real-Time Polymerase Chain Reaction, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids. https://app.cochat.ai/papers/10.1371/journal.pone.0038834
The paper
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., Sjövall, P., Magnusson, Y., Balvers, M. G. J., Verhoeckx, K. C. M., Tvrzicka, E., Bryhn, M., & Kopecky, J. (2012). Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids. PLoS ONE. https://doi.org/10.1371/journal.pone.0038834

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.